Is Madison Square Garden Sports Corp. (MSGS) Good For Your Portfolio?

Madison Square Garden Sports Corp. (NYSE:MSGS) saw a downside of -3.75% to close Friday at $178.06 after subtracting -$6.94 on the day. The 5-day average trading volume is 358,060 shares of the company’s common stock. It has gained $209.48 in the past week and touched a new high 1 time within the past 5 days. An average of 489,485 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 268,960.

MSGS’s 1-month performance is -7.21% or -$16.04 on its low of $177.78 reached on 08/18/23. The company’s shares have touched a 52-week low of $130.49 and high of $215.79, with the stock’s rally to the 52-week high happening on 07/31/23. YTD, MSGS has lost -2.87% or -$5.27 and has reached a new high 25 times. However, the current price is down -17.48% from the 52-week high price.

Top 5 AI Stocks to Buy for 2023

The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything. According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.

Click Here to Download the FREE Report.

Sponsored

Insider Transactions

MSGS stock investors last saw insider trading activity on May 11.Hopkinson David G. (President & COO) most recently sold 414 shares at $192.42 per share on May 11. This transaction cost the insider $79,662. President & COO, Hopkinson David G., sold 344 shares at a price of $188.82 on Mar 10.

Valuation Metrics

MSGS stock has a beta of 0.96. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 4.72 while the price to cash flow ratio at 23.97.

Madison Square Garden Sports Corp.’s quick ratio for the period ended June 29 was 0.50, with the current ratio over the same period at 0.50. In terms of profitability, the gross margin trailing 12 months is 47.90%. The trailing 12-month EBITDA margin is 44.06% while for the period ending June 29, Madison Square Garden Sports Corp.’s operating margin was 10.80%. The firm’s gross profit as reported stood at $338.64 million against revenue of $887.45 million.

Earnings Surprise

For the quarterly period ending June 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Net income grew 53.23% to $52.38 million, while revenue of $22.49 million was 57.06% off the previous quarter. Analysts expected MSGS to announce -$0.14 per share in earnings in its latest quarter, but it posted -$0.39, representing a -178.60% surprise. EBITDA for the quarter stood at more than -$11.32 million. MSGS stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 1.65 billion, with total debt at $1.12 billion. Shareholders hold equity totaling $23.89 million.

Let’s look briefly at Madison Square Garden Sports Corp. (MSGS) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 18 August was 19.53% to suggest the stock is trending oversold, with historical volatility in this time period at 49.94%.

The stock’s 5-day moving average is $197.10, reflecting a -14.37% or -$29.87 change from its current price. MSGS is currently trading -7.67% above its 20-day SMA, -6.41% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +0.88% and SMA200 by+13.70%.

Stochastic %K and %D was 12.46% and 35.85% and the average true range (ATR) pointed at 6.29. The RSI (14) points at 28.68%, while the 14-day stochastic is at 0.77% with the period’s ATR at 5.61. The stock’s 9-day MACD Oscillator is pointing at -12.28 and -15.22 on the 14-day charts.

Analyst Ratings

In the most recent analyst report for Madison Square Garden Sports Corp. (NYSE: MSGS), Seaport Research Partners launched coverage with a Neutral rating. Analysts offering their rating for MSGS stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate MSGS as a “sell,”, while 2 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 4 have offered a “buy” rating.

Most Popular

Related Posts